TY - JOUR
T1 - Loop ileostomy reversal after colon and rectal surgery
T2 - A single institutional 5-year experience in 944 patients
AU - Luglio, Gaetano
AU - Pendlimari, Rajesh
AU - Holubar, Stefan D.
AU - Cima, Robert R.
AU - Nelson, Heidi
PY - 2011/10
Y1 - 2011/10
N2 - Background: Diverting loop ileostomy is used to mitigate the sequelae of anastomotic dehiscence. Objective: To report the rate of complications after ileostomy reversal using standardized definitions to aid physicians who are deciding whether to divert anastomoses. Methods: Patients who underwent diverting loop ileostomy closure from January 1, 2005, through February 28, 2010, were identified using a prospective database. Perioperative variables and 30-day outcomes were reviewed. Complications were graded according to the Clavien- Dindo Classification, in which grade III, IV, or V represents major complications. Univariate analysis assessed the relationship between operative variables and surgical outcomes. Results:Atotal of 944 patients underwent reversal: 43.1% were women, the mean age was 47.2 years, the mean body mass index (calculated as weight in kilograms divided by height in meters squared) was 25.7, and 18.5% wereAmerican Society of Anesthesiologists class III or IV. Indications for the initial operation were ulcerative colitis (49.5%), rectal cancer (27.5%), diverticular disease (6.8%), and other (16.1%). Anastomotic technique for reversal was sutured fold-over in 466 patients (49.4%), stapled in 315 (33.4%), and handsewn end to end in 163 (17.3%). After reversal, the mean time to first bowel movement, tolerance of soft diet, and discharge from hospital was 2.6, 3.7, and 5.2 days, respectively. Handsewn cases had longer operative times and longer times to bowel movement, soft diet, and discharge. Overall, complications occurred in 203 patients (21.5%), including 45 patients (4.8%) who experienced a major complication; there were no deaths within 30 days. Conclusion: Ileostomy closure is associated with a low rate of major grade III and IV complications and should be reserved for patients who have a predicted postoperative major complication rate of 5% or more without diversion.
AB - Background: Diverting loop ileostomy is used to mitigate the sequelae of anastomotic dehiscence. Objective: To report the rate of complications after ileostomy reversal using standardized definitions to aid physicians who are deciding whether to divert anastomoses. Methods: Patients who underwent diverting loop ileostomy closure from January 1, 2005, through February 28, 2010, were identified using a prospective database. Perioperative variables and 30-day outcomes were reviewed. Complications were graded according to the Clavien- Dindo Classification, in which grade III, IV, or V represents major complications. Univariate analysis assessed the relationship between operative variables and surgical outcomes. Results:Atotal of 944 patients underwent reversal: 43.1% were women, the mean age was 47.2 years, the mean body mass index (calculated as weight in kilograms divided by height in meters squared) was 25.7, and 18.5% wereAmerican Society of Anesthesiologists class III or IV. Indications for the initial operation were ulcerative colitis (49.5%), rectal cancer (27.5%), diverticular disease (6.8%), and other (16.1%). Anastomotic technique for reversal was sutured fold-over in 466 patients (49.4%), stapled in 315 (33.4%), and handsewn end to end in 163 (17.3%). After reversal, the mean time to first bowel movement, tolerance of soft diet, and discharge from hospital was 2.6, 3.7, and 5.2 days, respectively. Handsewn cases had longer operative times and longer times to bowel movement, soft diet, and discharge. Overall, complications occurred in 203 patients (21.5%), including 45 patients (4.8%) who experienced a major complication; there were no deaths within 30 days. Conclusion: Ileostomy closure is associated with a low rate of major grade III and IV complications and should be reserved for patients who have a predicted postoperative major complication rate of 5% or more without diversion.
UR - http://www.scopus.com/inward/record.url?scp=80054774363&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80054774363&partnerID=8YFLogxK
U2 - 10.1001/archsurg.2011.234
DO - 10.1001/archsurg.2011.234
M3 - Article
C2 - 22006879
AN - SCOPUS:80054774363
SN - 2168-6254
VL - 146
SP - 1191
EP - 1196
JO - JAMA Surgery
JF - JAMA Surgery
IS - 10
ER -